1. Home
  2. FXNC vs ALEC Comparison

FXNC vs ALEC Comparison

Compare FXNC & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

N/A

Current Price

$28.75

Market Cap

258.1M

Sector

Finance

ML Signal

N/A

Logo Alector Inc.

ALEC

Alector Inc.

N/A

Current Price

$2.31

Market Cap

275.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FXNC
ALEC
Founded
1907
2013
Country
United States
United States
Employees
308
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.1M
275.8M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
FXNC
ALEC
Price
$28.75
$2.31
Analyst Decision
Hold
Buy
Analyst Count
3
8
Target Price
★ $33.00
$4.42
AVG Volume (30 Days)
12.7K
★ 1.8M
Earning Date
10-23-2026
11-05-2026
Dividend Yield
★ 2.63%
N/A
EPS Growth
★ 96.00
N/A
EPS
★ 1.93
0.70
Revenue
$7,717,000.00
★ $21,045,000.00
Revenue This Year
$7.52
$990.25
Revenue Next Year
$4.62
N/A
P/E Ratio
$15.02
★ $3.30
Revenue Growth
★ 7.40
N/A
52 Week Low
$23.71
$1.09
52 Week High
$33.24
$2.84

Technical Indicators

Market Signals
Indicator
FXNC
ALEC
Relative Strength Index (RSI) 37.27 51.94
Support Level $28.80 $1.90
Resistance Level $30.57 $2.67
Average True Range (ATR) 0.89 0.23
MACD -0.19 -0.01
Stochastic Oscillator 16.91 37.20

Price Performance

Historical Comparison
FXNC
ALEC

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: